HALO logo
halo search icon
Knight Therapeutics, Inc.

CA$8.18

Price Change Indicator
-0.09 (-1.088%)
Knight Therapeutics, Inc.
GUD · TSE

Knight Therapeutics, Inc.

Start Trading GUD for Free

CA$8.18

Price Arrow-0.09 (-1.088%)
20/05/2026 12:00:00 AM
All-CompaniesAll-ConsensusHALO AllHALO GrowthHALO Momentum
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Knight Therapeutics, Inc. Overview

GUD Health Scores

Short Term

Mean Reversion

Very Weak

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Strong

Garp

Neutral

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Weak

Balance Sheet

Very Weak

About GUD

icon
icon

Telephone

1.514.484.4483

icon

Address

Bureau 600, 100 Boul Alexis-Nihon, Montréal, QC H4M 2P2

Description

Knight Therapeutics, Inc. engages in the business of acquiring, in licensing, out-licensing, marketing, and commercializing pharmaceuticals products. The firm also focuses on building a portfolio of innovative products through in-licensing or acquiring product rights. The company was founded by Jonathan Ross Goodman on November 1, 2013 and is headquartered in Montréal, Canada.

GUD Price Chart

Key Stats

Market Cap

CA$810.75M

PE

240.30

EV/EBITDA

10.8

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 5.66 - 8.9

Trade Value (12mth)

US$84,658.00

1 week

-2.97%

1 month

10.24%

YTD

38.41%

1 year

42.01%

All time high

11.03

Key Fundamentals

EPS 3 yr Growth

-79.20%

EBITDA Margin

12.10%

Operating Cashflow

$70m

Free Cash Flow Return

8.50%

ROIC

-0.70%

Interest Coverage

5.20

Quick Ratio

1.60

Other Data

Shares Outstanding (Fully Diluted)

99m

HALO Sector

Healthcare

Next Company Report Date

25-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

CAD

Short Sell (% of issue)

0.00

GUD Fundamentals

Per Share Records

Historical data

Forecast data

CAD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.160.04-0.05locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.160.04-0.05locklocklock
Growth
 %locklocklocklock39.8127.4-225.9locklocklock
PE
 XlocklocklocklockN/A124.5240.3locklocklock
EV/EBITDA
 XlocklocklocklockN/AN/A10.8locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Knight Therapeutics, Inc. (GUD:TSE)?
Halo FAQ
The current share price of Knight Therapeutics, Inc. (GUD:TSE) is CAD$8.18.
What is the 52-week high share price for Knight Therapeutics, Inc. (GUD:TSE)?
Halo FAQ
The 52-week high share price for Knight Therapeutics, Inc. (GUD:TSE) is CAD$8.90.
What is the 52-week low share price for Knight Therapeutics, Inc. (GUD:TSE)?
Halo FAQ
The 52-week low share price for Knight Therapeutics, Inc. (GUD:TSE) is CAD$5.66.
What is the dividend yield for Knight Therapeutics, Inc. (GUD:TSE)?
Halo FAQ
Knight Therapeutics, Inc. (GUD:TSE) does not pay a dividend.
What was Knight Therapeutics, Inc. (GUD:TSE) last dividend payment?
Halo FAQ
Knight Therapeutics, Inc. (GUD:TSE) does not pay a dividend.
What is the franking level for Knight Therapeutics, Inc. (GUD:TSE)?
Halo FAQ
Knight Therapeutics, Inc. (GUD:TSE) has a franking level of 0.00%.
In which sector is Knight Therapeutics, Inc. (GUD:TSE) classified?
Halo FAQ
Knight Therapeutics, Inc. (GUD:TSE) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Knight Therapeutics, Inc. (GUD:TSE)?
Halo FAQ
The current P/E ratio for Knight Therapeutics, Inc. (GUD:TSE) is 240.30.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial